跳至主要内容
临床试验/RBR-5byrsc
RBR-5byrsc已完成未知

Effect of supplementation with a synbiotic on markers of the inflammatory response in children and adolescents with cystic fibrosis

niversidade Federal de Santa Catarina0 个研究点开始时间: 2016年3月11日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Intervention

入排标准

年龄范围
0Y 至 15Y(—)

入选标准

  • Cystic fibrosis group: Children and adolescents up to and including age zero and less than or equal to 15 years; to present a diagnosis of HR based on the sweat test (sweat chloride 60 mmol / L); clinically at least 30 days prior to data collection. For controls without cystic fibrosis: children and adolescents aged 0 years and 15 years without cystic fibrosis; clinically stable at least 30 days prior to data collection

排除标准

  • Subjects with fever, trauma, inflammatory diseases (asthma, inflammatory bowel disease, rheumatic disease), psychiatric, degenerative, cardiovascular, diabetes, glucose intolerance, renal failure, primary or secondary immunodeficiency Subjects undergoing antibiotic use at baseline, hormones, non-hormonal anti-inflammatory drugs, immunosuppressants and antihistamines, up to 30 days prior to data collection and subjects in pulmonary exacerbation

研究者

发起方
niversidade Federal de Santa Catarina

相似试验